
Keywords: Lipid metabolism; Cholesterol; LDL; PCSK9; FCHL; FCHL; familial combined hyperlipidemia; LDLR; LDL receptor; PCSK9; proprotein convertase subtilisin kexin type 9; SREBP2; sterol regulatory element binding protein 2; LDL-C; LDL cholesterol; HDL-C; HDL chol